International Business News - SEPR http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Sepracor Inc. said Wednesday it expects to ask the Food and Drug Administration for approval of an epilepsy drug candidate by the end of 2008 or early 2009. http://www.ibtimes.com/articles/20080924/sepracor-sees-fda-filing-by-late-2008-early-2009.htm Wed, 24 Sep 2008 16:38:53 EDT Acadia Pharmaceuticals Inc. said Tuesday it will cut its work force in half as it restructures to cut expenses and focus on a few late-stage drug candidates. http://www.ibtimes.com/articles/20080805/acadia-slashes-jobs-and-development-to-cut-costs.htm Tue, 05 Aug 2008 09:06:03 EDT Acadia Pharmaceuticals Inc. posted a larger second-quarter loss Tuesday as research costs increased and several drug development collaborations ended, slowing its revenue to a trickle. http://www.ibtimes.com/articles/20080805/acadia-2q-loss-grows-as-partnership-revenue-drops.htm Tue, 05 Aug 2008 09:02:01 EDT Generic drug maker Barr Pharmaceuticals Inc. said Thursday it is challenging a patent supporting 5 mg tablets of the hay fever drug Xyzal. The patent on Xyzal is held by Belgian drug maker UCB Inc. Barr says U.S. sales of the drug totaled $74 million for the 12 months ending May 31. Barr said UCB filed a lawsuit Wednesday to prevent it from bringing a generic version of Xyzal, or levocetirizine dihydrochloride, to the market. http://www.ibtimes.com/articles/20080731/barr-pharma-challenges-patent-on-hay-fever-drug.htm Thu, 31 Jul 2008 14:38:12 EDT Among the stock activity stories for Tuesday, July 29, from AP Financial News: NEW YORK (AP)--Merrill Lynch & Co. shares fell sharply Tuesday after the brokerage announced it would take a $5.7 billion write-down in the third quarter and unload a large slice of risky mortgage-backed securities. http://www.ibtimes.com/articles/20080729/movers-roundup-merrill-lynch-zoran.htm Tue, 29 Jul 2008 14:26:07 EDT Shares of drug developer Sepracor Inc. fell Tuesday after the company reported second-quarter profit well below Wall Street forecasts and cut revenue guidance. http://www.ibtimes.com/articles/20080729/sepracor-shares-fall-on-wide-2q-miss-outlook.htm Tue, 29 Jul 2008 19:43:44 EDT Among the earnings stories for Tuesday, July 29, from AP Financial News: PITTSBURGH (AP)--United States Steel Corp. says its profit more than doubled in the second quarter, surpassing Wall Street's expectations, on increased demand and pricing. http://www.ibtimes.com/articles/20080729/earnings-roundup-us-steel-earthlink.htm Tue, 29 Jul 2008 10:46:25 EDT Among the earnings projection stories for Tuesday, July 29, from AP Financial News: NEW YORK (AP)--Martha Stewart Living Omnimedia Inc., the New York-based media and publishing company, on Tuesday reaffirmed its full-year profit guidance, despite an uncertain economic environment. http://www.ibtimes.com/articles/20080729/outlook-roundup-martha-stewart-lear.htm Tue, 29 Jul 2008 10:22:44 EDT Sepracor Inc., which makes respiratory and central nervous disorder treatments, boosted its 2008 profit outlook on a tax benefit, but lowered its full-year revenue outlook Tuesday. http://www.ibtimes.com/articles/20080729/sepracor-hikes-2008-profit-outlook-sales-view-cut.htm Tue, 29 Jul 2008 09:29:43 EDT Sepracor Inc., which makes respiratory and central nervous disorder treatments, said Tuesday its second-quarter profit surged on a hefty tax benefit, though the results fell short of Wall Street expectations. http://www.ibtimes.com/articles/20080729/sepracor-2q-profit-surges-on-tax-benefit.htm Tue, 29 Jul 2008 09:27:49 EDT Among the stock activity stories for Thursday, June 19, from AP Financial News: NEW YORK (AP)--Shares of Sepracor Inc. rose Thursday as the drug maker reported positive results from a late-stage trial of a seizure drug candidate, and a UBS analyst upgraded the stock to "Buy" from "Neutral," citing its low share price and growth prospects. http://www.ibtimes.com/articles/20080619/movers-roundup-sepracor-scotts-miracle-gro.htm Thu, 19 Jun 2008 14:51:46 EDT Shares of Sepracor Inc. rose Thursday as the drug maker reported positive results from a late-stage trial of a seizure drug candidate, and a UBS analyst upgraded the stock to "Buy" from "Neutral" citing its low share price and growth prospects. http://www.ibtimes.com/articles/20080619/sepracor-shares-rise-on-trial-data-ubs-upgrade.htm Thu, 19 Jun 2008 10:58:52 EDT Drug maker Sepracor Inc. said Thursday that late-stage studies of an epilepsy drug demonstrated a reduction in the frequency of seizure in patients given the drug, eslicarbazepine, along with standard anti-epileptic drugs. http://www.ibtimes.com/articles/20080619/sepracor-epilepsy-drug-shown-to-reduce-seizures.htm Thu, 19 Jun 2008 07:57:54 EDT An executive vice president at drug maker Sepracor Inc. sold 5,500 shares of common stock, according to a Securities and Exchange Commission filing Thursday. http://www.ibtimes.com/articles/20080606/sepracor-evp-sells-shares.htm Fri, 06 Jun 2008 16:02:12 EDT Drug maker Sepracor Inc. said Thursday that Chief Financial Officer David P. Southwell has resigned and will be replaced by Executive Vice President Robert F. Scumaci. http://www.ibtimes.com/articles/20080515/sepracor-cfo-resigns-to-be-replaced-by-exec-vp.htm Thu, 15 May 2008 07:32:00 EDT Among the earnings stories for Friday, May 2, from AP Financial News: NEW YORK (AP) _ Strong sales of the video game "Rock Band" helped lift first-quarter earnings 33 percent at the entertainment company Viacom Inc., a major cable network operator which owns MTV and Nickelodeon. http://www.ibtimes.com/articles/20080502/earnings-roundup-viacom-cirrus-logic.htm Fri, 02 May 2008 14:50:55 EDT Shares of drug developer Sepracor Inc. fell Friday as Wall Street expressed disappointment over lagging sales of the company's insomnia treatment Lunesta and the decline in first-quarter revenue. http://www.ibtimes.com/articles/20080502/sepracor-shares-fall-as-revenue-disappoints-wall-street.htm Fri, 02 May 2008 12:32:18 EDT Among the earnings projection stories for Thursday, May 1, from AP Financial News: HUNTERSVILLE, N.C. (AP) _ Orthopedic product maker Orthofix International raised its full-year profit guidance Thursday on expected cost reductions. http://www.ibtimes.com/articles/20080501/outlook-roundup-orthofix-monro-muffler-brake.htm Thu, 01 May 2008 17:39:35 EDT Sepracor Inc., which makes respiratory and central nervous disorder treatments, reaffirmed its 2008 profit and revenue guidance on Thursday. The company expects profit between $1.05 and $1.45 per share on revenue between $1.35 billion and $1.45 billion. The company's outlook includes charges for the buyout of exclusive U.S. rights to several of Nycomed's respiratory treatments. http://www.ibtimes.com/articles/20080501/sepracor-reaffirms-2008-profit-and-revenue-outlook.htm Thu, 01 May 2008 10:08:26 EDT Sepracor Inc. said Thursday it will buy Oryx Pharmaceuticals Inc., a Canadian marketer of branded prescription drugs to doctors and hospitals, in a move to expand into the Canadian market. http://www.ibtimes.com/articles/20080501/sepracor-to-buy-canadas-oryx-pharma-to-move-into-market.htm Thu, 01 May 2008 09:24:39 EDT